Common Stock, Shares, Outstanding of ABVC BIOPHARMA, INC. from 30 Sep 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ABVC BIOPHARMA, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2010 to 31 Dec 2025.
  • ABVC BIOPHARMA, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 25,053,193, a 81% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 25,053,193 +11,184,709 +81% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 24,190,340 +11,478,995 +90% 30 Sep 2025 10-Q/A 03 Mar 2026 2025 Q3
Q2 2025 19,533,416 +7,481,593 +62% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 15,378,305 +4,679,990 +44% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 13,868,484 +5,928,186 +75% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 12,711,345 +7,888,302 +164% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 12,051,823 +8,743,749 +264% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 10,698,315 -22,382,425 -68% 31 Mar 2024 10-Q 17 May 2024 2024 Q1
Q4 2023 7,940,298 +4,654,108 +142% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 4,823,043 -27,809,286 -85% 30 Sep 2023 10-Q 15 Nov 2023 2023 Q3
Q2 2023 3,308,074 -28,999,255 -90% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 33,080,740 +2,773,411 +9.2% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 3,286,190 -21,134,336 -87% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 32,632,329 +4,696,546 +17% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 32,307,329 +7,836,803 +32% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 30,307,329 +5,886,803 +24% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 24,420,526 0 0% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 27,935,783 +7,541,880 +37% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 24,470,526 +4,982,358 +26% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 24,420,526 +4,932,358 +25% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 24,420,526 +4,942,358 +25% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 20,393,903 +915,735 +4.7% 30 Sep 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 19,488,168 +1,365,972 +7.5% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 19,488,168 +1,794,543 +10% 31 Mar 2020 10-Q 29 Jun 2020 2020 Q1
Q4 2019 19,478,168 +7,593,364 +64% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 19,478,168 -194,448,307 -91% 30 Sep 2019 10-Q 18 Nov 2019 2019 Q3
Q2 2019 18,122,196 -195,804,279 -92% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 17,693,625 -196,232,850 -92% 31 Mar 2019 10-Q 28 May 2019 2019 Q1
Q4 2018 11,884,804 -201,861,843 -94% 31 Dec 2018 10-K 15 May 2020 2019 FY
Q3 2018 213,926,475 +179,828 +0.08% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 213,926,475 +179,828 +0.08% 30 Jun 2018 10-Q 20 Aug 2018 2018 Q2
Q1 2018 213,926,475 +179,828 +0.08% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 213,746,647 +2,925,000 +1.4% 31 Dec 2017 10-K 15 Apr 2019 2018 FY
Q3 2017 213,746,647 +2,925,000 +1.4% 30 Sep 2017 10-KT 13 Apr 2018 2017 FY
Q2 2017 213,746,647 +4,393,750 +2.1% 30 Jun 2017 10-Q 19 Mar 2018 2017 Q3
Q1 2017 213,746,647 +4,987,826 +2.4% 31 Mar 2017 10-Q/A 19 Mar 2018 2017 Q2
Q4 2016 210,821,647 +145,390,503 +222% 31 Dec 2016 10-Q/A 19 Mar 2018 2017 Q1
Q3 2016 210,821,647 +44,547,726 +27% 30 Sep 2016 10-Q 19 Mar 2018 2017 Q3
Q2 2016 209,352,897 +154,759,865 +283% 30 Jun 2016 10-Q 22 Feb 2017 2016 Q3
Q1 2016 208,758,821 +154,165,789 +282% 31 Mar 2016 10-Q 17 May 2016 2016 Q2
Q4 2015 65,431,144 +10,838,112 +20% 31 Dec 2015 10-Q 23 Feb 2016 2016 Q1
Q3 2015 166,273,921 +166,262,777 30 Sep 2015 10-K/A 22 Sep 2017 2016 FY
Q2 2015 54,593,032 0 0% 30 Jun 2015 10-Q 19 Aug 2015 2015 Q3
Q1 2015 54,593,032 0 0% 31 Mar 2015 10-Q 05 Jun 2015 2015 Q2
Q4 2014 54,593,032 0 0% 31 Dec 2014 10-Q 17 Apr 2015 2015 Q1
Q3 2014 11,144* -54,581,888 30 Sep 2014 10-Q 23 Feb 2016 2016 Q1
Q2 2014 54,593,032 0 0% 30 Jun 2014 10-Q 17 Apr 2015 2014 Q3
Q1 2014 54,593,032 0 0% 31 Mar 2014 10-Q 17 Apr 2015 2014 Q2
Q4 2013 54,593,032 0 0% 31 Dec 2013 10-Q 17 Apr 2015 2014 Q1
Q3 2013 54,593,032 +40,434,526 +286% 30 Sep 2013 10-Q 17 Apr 2015 2015 Q1
Q2 2013 54,593,032 +53,218 +0.1% 30 Jun 2013 10-Q 16 Apr 2015 2013 Q3
Q1 2013 54,593,032 +38,261,150 +234% 31 Mar 2013 10-Q 16 Apr 2015 2013 Q2
Q4 2012 54,593,032 +38,261,150 +234% 31 Dec 2012 10-Q 16 Apr 2015 2013 Q1
Q3 2012 14,158,506 0 0% 30 Sep 2012 10-K 16 Apr 2015 2013 FY
Q2 2012 54,539,814 +43,881,308 +412% 30 Jun 2012 10-Q/A 20 Aug 2012 2012 Q3
Q1 2012 16,331,882 31 Mar 2012 10-Q 15 May 2012 2012 Q2
Q4 2011 16,331,882 31 Dec 2011 10-Q 21 Feb 2012 2012 Q1
Q3 2011 14,158,506 -18,752,178 -57% 30 Sep 2011 10-K 15 Apr 2015 2012 FY
Q2 2011 10,658,506 30 Jun 2011 10-Q/A 08 Sep 2011 2011 Q3
Q3 2010 32,910,684 30 Sep 2010 10-K/A 28 Dec 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.